Pay in 4 interest-free payments of $5.77 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
The deadline for 503A pharmacies was February 18, 2025, and for 503B outsourcing facilities was March 19, 2025
Side effects and perceived lack of efficacy (no results perceived) each accounted for 8% of discontinuations
Retatrutide has shown favorable effects on various cardiovascular parameters, making it a valuable tool in managing cardiovascular comorbidities
Clin Pharmacokinet 1988;15:227-44
Storage and handling differences between the medications If you are transitioning from compounded semaglutide to compounded tirzepatide, storage requirements differ slightly and are worth reviewing
Accessed June 16, 2025
US$ 24.59
US$ 20.68
US$ 26.06
US$ 28.01
US$ 29.64
US$ 22.47
